CVS Group plc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Richard William Mark Fairman
- Full Time Employees
- 9,000
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- CVS House Diss NO United Kingdom IP22 4ER
- IPO Date
- Oct 10, 2007
- Website
- cvsukltd.co.uk
- Similar Companies
- Business
- CVS Group plc is a leading provider of integrated veterinary services, encompassing a wide array of animal care offerings. The company operates through distinct divisions: Veterinary Practices, Laboratories, Crematoria, and an Online Retail Business. It manages numerous veterinary practices that deliver first-opinion treatment, specialist referral services, and out-of-hours emergency care for companion, equine, and farm animals across the United Kingdom and Australia. The Laboratories segment provides comprehensive diagnostic services, including biochemistry, hematology, and histology, supporting both its own practices and external veterinary clinics. Its Crematoria division offers pet cremation and clinical waste disposal services to veterinary practices and directly to pet owners. Additionally, the Animed Direct online retail platform supplies prescription and non-prescription medications, premium pet foods, and various pet care products. The group also manages pet health plans like The Healthy Pet Club, operates buying groups, and offers veterinary consumables. As of recent reports, CVS Group encompasses approximately 500 veterinary practices, including referral hospitals and dedicated out-of-hours sites, alongside three diagnostic laboratories and seven crematoria. The company, founded in 1999 and headquartered in Diss, United Kingdom, is currently undertaking a strategic move from the AIM market to the Main Market of the London Stock Exchange in early 2026 and has initiated a £20 million share buyback program. It is also actively expanding its presence through acquisitions in the Australian veterinary market.
Company News
CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript
CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript
CVS Group plc (CVSGF) Q4 2026 Earnings Call Prepared Remarks Transcript
CVS Group plc (CVSGF) Discusses Capital Investments in Facilities, Clinical Equipment and Technology to Drive Returns Transcript
CVS Group Q4 Earnings Call Highlights
Converium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share Buyback
UK's CVS Group CEO to step down after 7 years at the helm
CVS Group plc (CVSGF) Shareholder/Analyst Call Transcript
CVS Group plc (CVSGF) Q2 2026 Earnings Call Prepared Remarks Transcript
UK's CVS Group plans Main Market move, approves near $27 million buyback
CVS Group plc (CVSGF) Q4 2025 Earnings Call Prepared Remarks Transcript
CVS Group plc (CVSGF) Q4 2025 Earnings Call Transcript
CVS Group earnings 'in line' with guidance as it awaits CMA outcome
Intel faces possible split, CVS group president: Market Domination